Editas Medicine, Inc. Common Stock (EDIT) is a publicly traded Healthcare sector company. As of September 22, 2026, EDIT trades at $2.84 with a market cap of $414.67M and a P/E ratio of -4.23. EDIT moved +4.81% today. Year to date, EDIT is +38.05%; over the trailing twelve months it is +0.00%. Its 52-week range spans $0.91 to $4.54. Analyst consensus is buy with an average price target of $5.75. Rallies surfaces EDIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest EDIT news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $2.84 |
| Market Cap | $414.67M |
| P/E Ratio | -4.23 |
| EPS | $-0.68 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.54 |
| 52-Week Low | $0.91 |
| Volume | 2.09M |
| Avg Volume | 0 |
| Revenue (TTM) | $47.01M |
| Net Income | $-73.95M |
| Gross Margin | 0.00% |
6 analysts cover EDIT: 0 strong buy, 4 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.75.